期刊文献+

中药Ⅰ期临床耐受性试验的设计与实施 被引量:1

Design and Implementation of Chinese Medicine Phase Ⅰ Clinical Tolerance Test
下载PDF
导出
摘要 针对Ⅰ期临床耐受性试验的现状,从现行法规和技术要求,并结合工作经验,重点论述了中药Ⅰ期临床试验设计与实施中应注意的问题,尤其是在试验时需要把握的质量控制要点,如知情同意书设计、试验实施过程的质控等。 According to the situation of the phase I clinical tolerance test, from the current regulations and technology, combined with the work experience, the paper focuses that the design and the implementation should pay attention to clinical trials of traditional Chinese medicine in stage I in question, especially the quality control points in the test needs, such as informed consent design, test implementation process quality control.
作者 张锡玮
出处 《辽宁中医药大学学报》 CAS 2013年第8期24-26,共3页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 中药 Ⅰ期临床 设计 实施 traditional Chinese medicine phase I clinical design implementation
  • 相关文献

参考文献4

二级参考文献8

  • 1李家泰.临床药理学(第2版)[M].北京:人民卫生出版社,1998.361-368.
  • 2KOHN EC,REED E,SAROSY G,et al. Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers[J]. CancerRes,1996,56(3): 569-573.
  • 3BERLIN J,TUTSCH KD,HUTSON P, et al. Phase Ⅰ clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor[J]. J Clin Oncol, 1997,15 (2) :781 - 789.
  • 4KOHN EC ,FIGG WD ,SAROSY GA ,et al. Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations[J]. J Clin Oncol,1997,15(5): 1985-1993.
  • 5孙瑞元.新药Ⅰ期临床研究[A]..中药新药临床研究指导原则培训班讲义[C].北京,2002.151.
  • 6中野重行.医药品开发与临床试验[M].北京:科学出版社,1995..
  • 7张培彤,朴炳奎,富力,赵福秀,鲁歧.爱康胶囊I期临床试验研究[J].中国新药杂志,1999,8(5):328-330. 被引量:16
  • 8李青,冯奉仪,董梅,罗扬.尿多酸肽注射液I期临床耐受性研究[J].中国新药杂志,2002,11(7):561-563. 被引量:2

共引文献48

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部